- Home
- FBRT vs XNCR Comparison
FBRT vs XNCR Comparison
Compare FBRT & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FBRT | XNCR |
|---|---|---|
| Founded | 2012 | 1997 |
| Country | United States | United States |
| Employees | 223 | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 701.9M | 881.9M |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | FBRT | XNCR |
|---|---|---|
| Price | $8.52 | $11.21 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 9 |
| Target Price | $11.50 | ★ $22.33 |
| AVG Volume (30 Days) | ★ 736.9K | 712.4K |
| Earning Date | 04-29-2026 | 05-08-2026 |
| Dividend Yield | ★ 15.83% | N/A |
| EPS Growth | N/A | ★ 65.36 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $125,576,000.00 |
| Revenue This Year | $12.34 | N/A |
| Revenue Next Year | $4.95 | $4.80 |
| P/E Ratio | $13.56 | ★ N/A |
| Revenue Growth | N/A | ★ 13.65 |
| 52 Week Low | $8.24 | $6.92 |
| 52 Week High | $11.84 | $18.69 |
Technical Indicators
Market Signals| Indicator | FBRT | XNCR |
|---|---|---|
| Relative Strength Index (RSI) | 37.71 | 42.24 |
| Support Level | $8.38 | $11.02 |
| Resistance Level | $9.26 | $13.28 |
| Average True Range (ATR) | 0.21 | 0.72 |
| MACD | -0.06 | -0.16 |
| Stochastic Oscillator | 6.83 | 24.53 |
Price Performance
Historical ComparisonAbout FBRT Franklin BSP Realty Trust Inc.
Franklin BSP Realty Trust Inc is a private real estate investment trust that originates, acquires, and manages a diversified portfolio of commercial real estate debt, and first mortgage loans. secured by properties located in the United States. The Company's operations are organized into two business units: (i) Commercial Real Estate Financing, and (ii) Agency Business. Its four reporting segments are as follows: The real estate debt business, The Agency Business, The commercial real estate conduit business, and The real estate owned business.
About XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.